Literature DB >> 27864552

Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.

Julie M Fox1, Michael S Diamond2,3,4,5.   

Abstract

Chikungunya virus (CHIKV) is a re-emerging alphavirus that causes debilitating acute and chronic arthritis. Infection by CHIKV induces a robust immune response that is characterized by production of type I IFNs, recruitment of innate and adaptive immune cells, and development of neutralizing Abs. Despite this response, chronic arthritis can develop in some individuals, which may be due to a failure to eliminate viral RNA and Ag and/or persistent immune responses that cause chronic joint inflammation. In this review, based primarily on advances from recent studies in mice, we discuss the innate and adaptive immune factors that control CHIKV dissemination and clearance or contribute to pathogenesis.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27864552      PMCID： PMC5120763          DOI： 10.4049/jimmunol.1601426

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  86 in total

1.  Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic.

Authors:  Vidya A Arankalle; Shubham Shrivastava; Sarah Cherian; Rashmi S Gunjikar; Atul M Walimbe; Santosh M Jadhav; A B Sudeep; Akhilesh C Mishra
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

2.  Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Authors:  Scott A Smith; Laurie A Silva; Julie M Fox; Andrew I Flyak; Nurgun Kose; Gopal Sapparapu; Solomiia Khomandiak; Solomiia Khomadiak; Alison W Ashbrook; Kristen M Kahle; Rachel H Fong; Sherri Swayne; Benjamin J Doranz; Charles E McGee; Mark T Heise; Pankaj Pal; James D Brien; S Kyle Austin; Michael S Diamond; Terence S Dermody; James E Crowe
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

3.  Bindarit: an anti-inflammatory small molecule that modulates the NFκB pathway.

Authors:  Eugenio Mora; Angelo Guglielmotti; Giuseppe Biondi; Paolo Sassone-Corsi
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

Review 4.  Chikungunya fever: an epidemiological review of a re-emerging infectious disease.

Authors:  J Erin Staples; Robert F Breiman; Ann M Powers
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

5.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

6.  An animal model for studying the pathogenesis of chikungunya virus infection.

Authors:  Sarah A Ziegler; Liang Lu; Amelia P A Travassos da Rosa; Shu-Yuan Xiao; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2008-07       Impact factor: 2.345

7.  Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Authors:  Pankaj Pal; Julie M Fox; David W Hawman; Yan-Jang S Huang; Ilhem Messaoudi; Craig Kreklywich; Michael Denton; Alfred W Legasse; Patricia P Smith; Syd Johnson; Michael K Axthelm; Dana L Vanlandingham; Daniel N Streblow; Stephen Higgs; Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

8.  Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Authors:  David W Hawman; Kristina A Stoermer; Stephanie A Montgomery; Pankaj Pal; Lauren Oko; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

9.  Notes from the field: Transmission of chikungunya virus in the continental United States--Florida, 2014.

Authors:  Katherine Kendrick; Danielle Stanek; Carina Blackmore
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-05       Impact factor: 17.586

10.  Novel Lesions of Bones and Joints Associated with Chikungunya Virus Infection in Two Mouse Models of Disease: New Insights into Disease Pathogenesis.

Authors:  Brad A Goupil; Margaret A McNulty; Matthew J Martin; Michael K McCracken; Rebecca C Christofferson; Christopher N Mores
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240
View more
  25 in total

1.  Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.

Authors:  Lindsey E Cook; Marissa C Locke; Alissa R Young; Kristen Monte; Matthew L Hedberg; Raeann M Shimak; Kathleen C F Sheehan; Deborah J Veis; Michael S Diamond; Deborah J Lenschow
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

2.  Human CD8 T-cell activation in acute and chronic chikungunya infection.

Authors:  Cinthia Nóbrega de Sousa Dias; Bruna Macêdo Gois; Viviane Silva Lima; Isabel Cristina Guerra-Gomes; Josélio Maria Galvão Araújo; Juliana de Assis Silva Gomes; Demétrius Antônio Machado Araújo; Isac Almeida Medeiros; Fátima de Lourdes Assunção Araújo de Azevedo; Robson Cavalcanti Veras; Daniele Idalino Janebro; Ian Porto Gurgel do Amaral; Tatjana Souza Lima Keesen
Journal:  Immunology       Date:  2018-09-03       Impact factor: 7.397

3.  IL-18: a suggested target for immunomodulation in chikungunya virus infection.

Authors:  Chintana Chirathaworn; Jira Chansaenroj; Pornsuri Pongsuchart; Yong Poovorawan
Journal:  Arch Virol       Date:  2020-10-19       Impact factor: 2.574

4.  Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.

Authors:  Sharmila Nair; Subhajit Poddar; Raeann M Shimak; Michael S Diamond
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

5.  Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.

Authors:  Marcilio Jorge Fumagalli; William Marciel de Souza; Luiza Antunes de Castro-Jorge; Renan Villanova Homem de Carvalho; Ítalo de Araújo Castro; Luiz Gustavo Nogueira de Almeida; Silvio Roberto Consonni; Dario Simões Zamboni; Luiz Tadeu Moraes Figueiredo
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

6.  Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages.

Authors:  P Sanjai Kumar; Tapas K Nayak; Chandan Mahish; Subhransu S Sahoo; Anukrishna Radhakrishnan; Saikat De; Ankita Datey; Ram P Sahu; Chandan Goswami; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Arch Virol       Date:  2020-10-30       Impact factor: 2.574

7.  Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.

Authors:  Kaustuv Nayak; Vineet Jain; Manpreet Kaur; Naushad Khan; Kamalvishnu Gottimukkala; Charu Aggarwal; Rohit Sagar; Shipra Gupta; Ramesh Chandra Rai; Kritika Dixit; Mohammad Islamuddin; Wajihul Hasan Khan; Anil Verma; Deepti Maheshwari; Yadya M Chawla; Elluri Seetharami Reddy; Harekrushna Panda; Pragati Sharma; Priya Bhatnagar; Prabhat Singh; Siva Raghavendhar B; Ashok Kumar Patel; Vinod H Ratageri; Anmol Chandele; Pratima Ray; Kaja Murali-Krishna
Journal:  JCI Insight       Date:  2020-04-09

8.  Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Authors:  Erin D Lucas; Jeffrey M Finlon; Matthew A Burchill; Mary K McCarthy; Thomas E Morrison; Tonya M Colpitts; Beth A Jirón Tamburini
Journal:  J Immunol       Date:  2018-07-25       Impact factor: 5.422

9.  A Critical Role for STING Signaling in Limiting Pathogenesis of Chikungunya Virus.

Authors:  Tingting Geng; Tao Lin; Duomeng Yang; Andrew G Harrison; Anthony T Vella; Erol Fikrig; Penghua Wang
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

10.  Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.

Authors:  Bryan Gall; Kara Pryke; Jinu Abraham; Nobuyo Mizuno; Sara Botto; Tina M Sali; Rebecca Broeckel; Nicole Haese; Aaron Nilsen; Andrew Placzek; Thomas Morrison; Mark Heise; Daniel Streblow; Victor DeFilippis
Journal:  J Virol       Date:  2018-02-26       Impact factor: 6.549
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.